Literature DB >> 2686408

Safety of ciprofloxacin based on phase IV studies ("Anwendungsbeobachtung") in the Federal Republic of Germany.

C Reiter1, M Pfeiffer, R N Hullman.   

Abstract

Mesh:

Substances:

Year:  1989        PMID: 2686408     DOI: 10.1016/0002-9343(89)90034-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  7 in total

Review 1.  Clinical pharmacokinetics of ciprofloxacin.

Authors:  K Vance-Bryan; D R Guay; J C Rotschafer
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

2.  Post-marketing surveillance of quinolones 1988-1990.

Authors:  P G Davey; T McDonald; G Lindsay
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

Review 3.  Safety of ciprofloxacin in children: worldwide clinical experience based on compassionate use. Emphasis on joint evaluation.

Authors:  V Chyský; K Kapila; R Hullmann; G Arcieri; P Schacht; R Echols
Journal:  Infection       Date:  1991 Jul-Aug       Impact factor: 3.553

4.  Safety of trovafloxacin in treatment of lower respiratory tract infections.

Authors:  D Williams; S Hopkins
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-06       Impact factor: 3.267

Review 5.  Safety and efficacy of ciprofloxacin in paediatric patients--review.

Authors:  R Kubin
Journal:  Infection       Date:  1993 Nov-Dec       Impact factor: 3.553

Review 6.  Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.

Authors:  R Davis; A Markham; J A Balfour
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

7.  Ciprofloxacin-Induced Reaction Imitating a Lupus Flare: A Case Report.

Authors:  Adnan Liaqat; Aisha Barlas; Talal Barlas; Hamna Khurram; Hamza Liaqat
Journal:  Cureus       Date:  2020-05-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.